BindingDB BDBM17636 2-{[3-(trifluoromethyl)phenyl]amino}benzoic acid::Arlef::CHEMBL23588::Flufenamic acid::Nichisedan::US20240002326, Compound Flufenamic acid::US9271961, Flufenamic Acid

BDBM17636 2-{[3-(trifluoromethyl)phenyl]amino}benzoic acid::Arlef::CHEMBL23588::Flufenamic acid::Nichisedan::US20240002326, Compound Flufenamic acid::US9271961, Flufenamic Acid

SMILES OC(=O)c1ccccc1Nc1cccc(c1)C(F)(F)F

InChI Key InChIKey=LPEPZBJOKDYZAD-UHFFFAOYSA-N

Data 3 KI 43 IC50 4 Kd 9 EC50

PDB links: 7 PDB IDs match this monomer.

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 17636

Myeloperoxidase(Homo sapiens (Human))
Universit£

Curated by ChEMBL

BDBM17636(2-{[3-(trifluoromethyl)phenyl]amino}benzoic acid |...)

IC50: 1.80E+3nMAssay Description:Inhibition of chlorinating activity of recombinant myeloperoxidase by taurine assayMore data for this Ligand-Target Pair

PDB MMDB Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar

Purchase ChEBI
CHEMBL DrugBank MCE
KEGG MMDB PC cid PC sid PDB Patents Similars

Details Article PubMed

Filter my 59 hits

Targets 21▿
- Aldo-keto reductase family 1 member C3 11
- Aldo-keto reductase family 1 member C2 8
- Prostaglandin G/H synthase 2 4
- Prostaglandin G/H synthase 1 4
- Transcriptional enhancer factor TEF-3 4
- Aldo-keto reductase family 1 member B10 3
- Transient receptor potential cation channel subfamily A member 1 3
- Aldo-keto reductase family 1 member C1 3
- Aldo-keto reductase family 1 member C4 2
- Transthyretin 2
- Aldo-keto reductase family 1 member B1 2
- Androgen receptor 2
- Transcription factor SOX-18 2
- Potassium channel subfamily K member 18 2
- Cytochrome c oxidase subunit 2 1
- Fatty acid-binding protein, intestinal 1
- Potassium channel subfamily K member 2 1
- Taste receptor type 2 member 14 1
- Myeloperoxidase 1
- Acid-sensing ion channel 5 1
- Transient receptor potential cation channel subfamily M member 2 1
- ...
Publications 27▿
- US Patent US9271961 (2016) 7
- Eur J Med Chem 62: 738-44 (2013) 6
- Eur J Med Chem 139: 936-946 (2017) 5
- J Med Chem 55: 7746-58 (2012) 4
- Eur J Med Chem 170: 141-156 (2019) 3
- J Med Chem 55: 2311-23 (2012) 3
- Eur J Med Chem 184: (2019) 3
- Bioorg Med Chem Lett 22: 3492-7 (2012) 2
- Bioorg Med Chem Lett 26: 4919-4924 (2016) 2
- J Med Chem 58: 2047-67 (2015) 2
- Eur J Med Chem 150: 930-945 (2018) 2
- Bioorg Med Chem Lett 21: 1464-8 (2011) 2
- Cancer Res 64: 1802-10 (2004) 2
- J Nat Prod 78: 2666-74 (2015) 2
- J Med Chem 64: 3976-3996 (2021) 1
- Proc Natl Acad Sci U S A 104: 4808-13 (2007) 1
- J Med Chem 63: 11972-11989 (2020) 1
- Bioorg Med Chem 16: 1702-20 (2008) 1
- J Med Chem 63: 14228-14242 (2020) 1
- Bioorg Med Chem Lett 25: 4437-40 (2015) 1
- J Med Chem 59: 5149-57 (2016) 1
- J Med Chem 29: 2347-51 (1986) 1
- US Patent US20240002326 (2024) 1
- ACS Chem Biol 4: 834-43 (2009) 1
- ACS Chem Biol 9: 2526-34 (2014) 1
- Cell Chem Biol 24: 346-359 (2017) 1
- J Med Chem 54: 8563-73 (2011) 1
Institutions 22▿
- University Of Auckland 10
- University of Pennsylvania 7
- University Of Torino 7
- University Of Pennsylvania 5
- Universit£ 4
- Shanghai Institute Of Materia Medica 3
- University Of Hull 3
- Pfizer 2
- Perelman School Of Medicine University Of Pennsylvania 2
- The University of Birmingham 2
- University Of Hradec Kralove 2
- St. Jude Research Hospital 1
- The University of Queensland 1
- Rwth Aachen University 1
- TBA 1
- Peking University 1
- Monash University 1
- University Of British Columbia 1
- University of Queensland 1
- University Of Toyama 1
- University Of California 1
- Max Planck Institute Of Molecular Physiology 1
Affinity: 16 to 2.6E+6 nM▿
- Ki 3
- IC50 43
- Kd 4
- EC50 9
- Affinity ≤ nM
Xtal structures: 1
Docked structures: 1
Catalog Cmpds: 1